The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1
Yi, Ming, Zhang, Jing, Li, Anping, Niu, Mengke, Yan, Yongxiang, Jiao, Ying, Luo, Suxia, Zhou, Pengfei, Wu, Kongming
Published in Journal of hematology and oncology (16.02.2021)
Published in Journal of hematology and oncology (16.02.2021)
Get full text
Journal Article
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Yi, Ming, Niu, Mengke, Zhang, Jing, Li, Shiyu, Zhu, Shuangli, Yan, Yongxiang, Li, Ning, Zhou, Pengfei, Chu, Qian, Wu, Kongming
Published in Journal of hematology and oncology (15.09.2021)
Published in Journal of hematology and oncology (15.09.2021)
Get full text
Journal Article
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
Yi, Ming, Wu, Yuze, Niu, Mengke, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Dai, Zhijun, Wu, Kongming
Published in Journal for immunotherapy of cancer (01.12.2022)
Published in Journal for immunotherapy of cancer (01.12.2022)
Get full text
Journal Article
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Yi, Ming, Niu, Mengke, Wu, Yuze, Ge, Hong, Jiao, Dechao, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Chu, Qian, Wu, Kongming
Published in Journal of hematology and oncology (08.10.2022)
Published in Journal of hematology and oncology (08.10.2022)
Get full text
Journal Article
A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells
Yu, Shengnan, Zhang, Jing, Yan, Yongxiang, Yao, Xudong, Fang, Lijuan, Xiong, Hui, Liu, Yang, Chu, Qian, Zhou, Pengfei, Wu, Kongming
Published in Journal of experimental & clinical cancer research (14.08.2019)
Published in Journal of experimental & clinical cancer research (14.08.2019)
Get full text
Journal Article
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
Pan, Xiaoyan, Shi, Jian, Hu, Xue, Wu, Yan, Zeng, Liang, Yao, Yanfeng, Shang, Weijuan, Liu, Kunpeng, Gao, Ge, Guo, Weiwei, Peng, Yun, Chen, Shaohong, Gao, Xiaoxiao, Peng, Cheng, Rao, Juhong, Zhao, Jiaxuan, Gong, Cheng, Zhou, Hui, Lu, Yudong, Wang, Zili, Hu, Xiliang, Cong, WenJuan, Fang, Lijuan, Yan, Yongxiang, Zhang, Jing, Xiong, Hui, Yi, Jizu, Yuan, Zhiming, Zhou, Pengfei, Shan, Chao, Xiao, Gengfu
Published in Cell discovery (07.09.2021)
Published in Cell discovery (07.09.2021)
Get full text
Journal Article
Subsequent malaria enhances virus-specific T cell immunity in SIV-infected Chinese rhesus macaques
Liu, Guangjie, Qin, Li, Li, Youjia, Zhao, Siting, Shugay, Mikhail, Yan, Yongxiang, Ye, Yijian, Chen, Yue, Huang, Cuizhu, Bayaer, Nashun, Adah, Dickson, Zhang, Hui, Su, Zhong, Chen, Xiaoping
Published in Cell communication and signaling (01.07.2022)
Published in Cell communication and signaling (01.07.2022)
Get full text
Journal Article
Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell
Yang, Rui, He, Qing, Zhou, Hui, Gong, Cheng, Wang, Xing, Song, Xingpan, Luo, Fang, Lei, Yang, Ni, Qian, Wang, Zili, Xu, Shasha, Xue, Yan, Zhang, Man, Wen, Haimei, Fang, Lijuan, Zeng, Liang, Yan, Yongxiang, Shi, Jian, Zhang, Jing, Yi, Jizu, Zhou, Pengfei
Published in Frontiers in immunology (17.06.2022)
Published in Frontiers in immunology (17.06.2022)
Get full text
Journal Article
Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells
Yang, Rui, Shen, Susu, Gong, Cheng, Wang, Xin, Luo, Fang, Luo, Fengyan, Lei, Yang, Wang, Zili, Xu, Shasha, Ni, Qian, Xue, Yan, Fu, Zhen, Zeng, Liang, Fang, Lijuan, Yan, Yongxiang, Zhang, Jing, Gan, Lu, Yi, Jizu, Zhou, Pengfei
Published in Frontiers in immunology (10.05.2021)
Published in Frontiers in immunology (10.05.2021)
Get full text
Journal Article
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model
Liu, Guangjie, Li, Youjia, Qin, Li, Yan, Yongxiang, Ye, Yijian, Chen, Yue, Huang, Cuizhu, Zhao, Siting, Yao, Yongchao, Su, Zhong, Chen, Xiaoping
Published in BMC infectious diseases (12.11.2019)
Published in BMC infectious diseases (12.11.2019)
Get full text
Journal Article
Low-temperature synthesis and sunlight-catalytic performance of flower-like hierarchical graphene oxide/ZnO macrosphere
Mei, Wei, Lin, Min, Chen, Chuansheng, Yan, Yongxiang, Lin, Liangwu
Published in Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology (01.11.2018)
Published in Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology (01.11.2018)
Get full text
Journal Article
The redirected killing of PD-L1 positive tumor cells by the expanded mucosa-associated invariant T (MAIT) cells is mediated with a bispecific antibody targeting TCR Vα7.2 and PD-L1
Yang, Rui, He, Qing, Zhang, Jing, Yan, Yongxiang, Shi, Jian, Zhou, Pengfei
Published in Biochemical and biophysical research communications (12.02.2023)
Published in Biochemical and biophysical research communications (12.02.2023)
Get full text
Journal Article
CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers
Jiao, Ying, Yi, Ming, Xu, Linping, Chu, Qian, Yan, Yongxiang, Luo, Suxia, Wu, Kongming
Published in Expert opinion on investigational drugs (01.11.2020)
Published in Expert opinion on investigational drugs (01.11.2020)
Get more information
Journal Article
항 ANG2 항체 및 그 제조방법과 응용
HUA SHAN, SHI JIAN, FANG LIJUAN, YAN YONGXIANG, ZHANG JING, ZHOU PENGFEI
Year of Publication 15.04.2024
Get full text
Year of Publication 15.04.2024
Patent
Combine and conquer: manganese synergizing anti-TGF-[beta]/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Yi, Ming, Niu, Mengke, Zhang, Jing, Li, Shiyu, Zhu, Shuangli, Yan, Yongxiang, Li, Ning, Zhou, Pengfei, Chu, Qian, Wu, Kongming
Published in Journal of hematology and oncology (15.09.2021)
Published in Journal of hematology and oncology (15.09.2021)
Get full text
Journal Article
Combination of oral STING agonist MSA-2 and anti-TGF-[beta]/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Yi, Ming, Niu, Mengke, Wu, Yuze, Ge, Hong, Jiao, Dechao, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Chu, Qian, Wu, Kongming
Published in Journal of hematology and oncology (08.10.2022)
Published in Journal of hematology and oncology (08.10.2022)
Get full text
Journal Article
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-[beta] and PD-L1
Yi, Ming, Zhang, Jing, Li, Anping, Niu, Mengke, Yan, Yongxiang, Jiao, Ying, Luo, Suxia, Zhou, Pengfei, Wu, Kongming
Published in Journal of hematology and oncology (16.02.2021)
Published in Journal of hematology and oncology (16.02.2021)
Get full text
Journal Article